EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-SA 4.0

Drug-Induced Liver Injury: Mechanisms, Diagnosis, and Management: A Review

Anuj C Keshari, Sunil N Thitame, Ashwini A Aher, Urmila C Keshari

Journal of Pharmacy and Bioallied Sciences · 2025-05 · 17 (Suppl 1) · S55-S58

DOI: 10.4103/jpbs.jpbs_568_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 29.04.2025. Verfasst von Anuj C Keshari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A BSTRACT Drug-induced liver injury (DILI) stands as the worldwide medical problem that causes substantial portions of both acute liver failure incidents and necessary liver transplants and fatalities. The liver functions as the main detoxifying organ of the body therefore, it becomes easily susceptible to destructive effects from the medicine components as well as other substances such as herbal supplements. DILI produces diverse liver damage that extends from unnoticed enzyme level elevations through the acute liver failure detection points. The purpose of this review assessment is to deliver an extensive breakdown of DILI pathogenic elements alongside diagnostic hurdles and present rule-of-the-art clinical practices. Researchers analyze three major pathophysiological mechanisms—oxidative stress, along with mitochondrial dysfunction and immune-mediated damage—for liver damage formation. The article explains diagnostic tools for DILI alongside establishing biomarkers and employment of liver biopsy for diagnosis. This discussion explores detailed information about the three management options that consist of drug withdrawal and supportive care together with liver transplantation. The discovery of genetic DILI susceptibilities combined with pharmacogenomic applications in clinical care leads to promising patient-specific treatments for better clinical achievements.

Schlagwörter

Stichwörter der Autor:innen

Biomarkersdrug-induced liver injuryhepatotoxicityimmune-mediated liver injuryliver biopsyliver failureliver transplantationmitochondrial dysfunctionoxidative stresspharmacogenomics

Autor:innen und Institutionen

  • Student, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
  • Professor and Dean, School of Allied Health Science, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
  • Biomedical Sciences, School of Allied Health Science, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
  • Department of Anesthesiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India.

Zitieren

APA

Keshari, A. C., Thitame, S. N., Aher, A. A., & Keshari, U. C. (2025). Drug-Induced Liver Injury: Mechanisms, Diagnosis, and Management: A Review. Journal of Pharmacy and Bioallied Sciences, 17(Suppl 1), S55-S58. https://doi.org/10.4103/jpbs.jpbs_568_25

Vancouver

Keshari AC, Thitame SN, Aher AA, Keshari UC. Drug-Induced Liver Injury: Mechanisms, Diagnosis, and Management: A Review. Journal of Pharmacy and Bioallied Sciences. 2025;17(Suppl 1):S55-S58. doi:10.4103/jpbs.jpbs_568_25

BibTeX
@article{Keshari2025,
  author = {Keshari, Anuj C and Thitame, Sunil N and Aher, Ashwini A and Keshari, Urmila C},
  title = {Drug-Induced Liver Injury: Mechanisms, Diagnosis, and Management: A Review},
  journal = {Journal of Pharmacy and Bioallied Sciences},
  year = {2025},
  volume = {17},
  number = {Suppl 1},
  pages = {S55--S58},
  doi = {10.4103/jpbs.jpbs_568_25}
}
Kostenlos starten →